Sökresultat - Marcus Unterrainer

Förfina resultatet
  1. 1
    First Clinical Results for PSMA-Targeted α-Therapy Using <sup>225</sup>Ac-PSMA-I&amp;T in Advanced-mCRPC Patients

    First Clinical Results for PSMA-Targeted α-Therapy Using <sup>225</sup>Ac-PSMA-I&amp;T in Advanced-mCRPC Patients av Mathias J. Zacherl, Franz Josef Gildehaus, Lena M. Mittlmeier, Guido Böning, Astrid Gosewisch, Vera Wenter, Marcus Unterrainer, Nina-Sophie Schmidt-Hegemann, Claus Belka, Alexander Kretschmer, Jozefina Casuscelli, Christian G. Stief, Marcus Unterrainer, Peter Bartenstein, Andrei Todica, Harun Ilhan

    Publicerad 2020
    Hämta fulltext Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  2. 2
    <sup>18</sup>F-Labeled Somatostatin Analogs as PET Tracers for the Somatostatin Receptor: Ready for Clinical Use

    <sup>18</sup>F-Labeled Somatostatin Analogs as PET Tracers for the Somatostatin Receptor: Ready for Clinical Use av Hannes Leupe, Stephen Ahenkorah, Jeroen Dekervel, Marcus Unterrainer, Eric Van Cutsem, Chris Verslype, Frederik Cleeren, Christophe M. Deroose

    Publicerad 2023
    Hämta fulltext Hämta fulltext
    Revisão
    Lägg till i favoriter
    Sparad:
  3. 3
    Identification of time-to-peak on dynamic 18F-FET-PET as a prognostic marker specifically in IDH1/2 mutant diffuse astrocytoma

    Identification of time-to-peak on dynamic 18F-FET-PET as a prognostic marker specifically in IDH1/2 mutant diffuse astrocytoma av Bogdana Suchorska, Armin Giese, Annamaria Biczok, Marcus Unterrainer, Michael Weller, Mark Drexler, Peter Bartenstein, Ulrich Schüller, Jörg‐Christian Tonn, Nathalie L. Albert

    Publicerad 2017
    Hämta fulltext Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  4. 4
    Towards standardization of 18F-FET PET imaging: do we need a consistent method of background activity assessment?

    Towards standardization of 18F-FET PET imaging: do we need a consistent method of background activity assessment? av Marcus Unterrainer, Franziska Vettermann, Matthias Brendel, Adrien Holzgreve, Michael Lifschitz, Matthias Zähringer, Bogdana Suchorska, Vera Wenter, Ben Illigens, Peter Bartenstein, Nathalie L. Albert

    Publicerad 2017
    Hämta fulltext Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  5. 5
    Serial <sup>18</sup>F-FET PET Imaging of Primarily <sup>18</sup>F-FET–Negative Glioma: Does It Make Sense?

    Serial <sup>18</sup>F-FET PET Imaging of Primarily <sup>18</sup>F-FET–Negative Glioma: Does It Make Sense? av Marcus Unterrainer, Florian Schweisthal, Bogdana Suchorska, Vera Wenter, Christine Schmid‐Tannwald, Wolfgang P. Fendler, Ulrich Schüller, Peter Bartenstein, Jörg‐Christian Tonn, Nathalie L. Albert

    Publicerad 2016
    Hämta fulltext Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  6. 6
    <sup>18</sup>F-FET PET Uptake Characteristics in Patients with Newly Diagnosed and Untreated Brain Metastasis

    <sup>18</sup>F-FET PET Uptake Characteristics in Patients with Newly Diagnosed and Untreated Brain Metastasis av Marcus Unterrainer, Norbert Galldiks, Bogdana Suchorska, Lara-Caroline Kowalew, Vera Wenter, Christine Schmid‐Tannwald, Maximilian Niyazi, Peter Bartenstein, Karl‐Josef Langen, Nathalie L. Albert

    Publicerad 2016
    Hämta fulltext Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  7. 7
    RECIP 1.0 + PSA for response assessment in mCRPC patients treated with 225Ac / 177Lu PSMA combination therapy

    RECIP 1.0 + PSA for response assessment in mCRPC patients treated with 225Ac / 177Lu PSMA combination therapy av Gabriel T. Sheikh, Astrid Delker, Mathias J. Zacherl, Adrien Holzgreve, Sarah L. Takayama Fouladgar, Marcus Unterrainer, Johannes Rübenthaler, Jozefina Casuscelli, Andrei Gafita, Lena M. Unterrainer

    Publicerad 2025
    Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  8. 8
    Suspected recurrence of brain metastases after focused high dose radiotherapy: can [18F]FET- PET overcome diagnostic uncertainties?

    Suspected recurrence of brain metastases after focused high dose radiotherapy: can [18F]FET- PET overcome diagnostic uncertainties? av Alexander Romagna, Marcus Unterrainer, Christine Schmid‐Tannwald, Matthias Brendel, Jörg‐Christian Tonn, Silke Birgit Nachbichler, Alexander Muacevic, Peter Bartenstein, Friedrich-Wilhelm Kreth, Nathalie L. Albert

    Publicerad 2016
    Hämta fulltext Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  9. 9
    Prediction of TERTp-mutation status in IDH-wildtype high-grade gliomas using pre-treatment dynamic [18F]FET PET radiomics

    Prediction of TERTp-mutation status in IDH-wildtype high-grade gliomas using pre-treatment dynamic [18F]FET PET radiomics av Zhicong Li, Lena Kaiser, Adrien Holzgreve, Viktoria Ruf, Bogdana Suchorska, Vera Wenter, Stefanie Quach, Jochen Herms, Peter Bartenstein, Jörg‐Christian Tonn, Marcus Unterrainer, Nathalie L. Albert

    Publicerad 2021
    Hämta fulltext Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  10. 10
    Salvage PRRT with 177Lu-DOTA-octreotate in extensively pretreated patients with metastatic neuroendocrine tumor (NET): dosimetry, toxicity, efficacy, and survival

    Salvage PRRT with 177Lu-DOTA-octreotate in extensively pretreated patients with metastatic neuroendocrine tumor (NET): dosimetry, toxicity, efficacy, and survival av Simon Rudisile, Astrid Gosewisch, Vera Wenter, Marcus Unterrainer, Guido Böning, Franz Josef Gildehaus, Wolfgang P. Fendler, Christoph J. Auernhammer, Christine Spitzweg, Peter Bartenstein, Andrei Todica, Harun Ilhan

    Publicerad 2019
    Hämta fulltext Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  11. 11
    [99mTc]Tc-antigranulocyte scintigraphy for prediction of bone marrow reserve prior to radioligand therapy in patients with metastatic castration resistant prostate cancer

    [99mTc]Tc-antigranulocyte scintigraphy for prediction of bone marrow reserve prior to radioligand therapy in patients with metastatic castration resistant prostate cancer av Sophie C. Kunte, Astrid Delker, Adrien Holzgreve, Mathias J. Zacherl, Maximilian Scheifele, Jozefina Casuscelli, Franz Josef Gildehaus, Marcus Unterrainer, Harun Ilhan, Rudolf A. Werner, Lena M. Unterrainer

    Publicerad 2025
    Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  12. 12
    PET/CT imaging for tumour response assessment to immunotherapy: current status and future directions

    PET/CT imaging for tumour response assessment to immunotherapy: current status and future directions av Marcus Unterrainer, Michael Ruzicka, Matthias P. Fabritius, Lena M. Mittlmeier, Michael Winkelmann, Johannes Rübenthaler, Matthias Brendel, Marion Subklewe, Michael von Bergwelt‐Baildon, Jens Ricke, Wolfgang G. Kunz, Clemens C. Cyran

    Publicerad 2020
    Hämta fulltext Hämta fulltext
    Revisão
    Lägg till i favoriter
    Sparad:
  13. 13
    Resting-state fMRI detects alterations in whole brain connectivity related to tumor biology in glioma patients

    Resting-state fMRI detects alterations in whole brain connectivity related to tumor biology in glioma patients av Veit M. Stoecklein, Sophia Stoecklein, Franziska Galiè, Jianxun Ren, Michael Schmutzer, Marcus Unterrainer, Nathalie L. Albert, Friedrich-W Kreth, Niklas Thon, Thomas Liebig, Birgit Ertl‐Wagner, Joerg-C. Tonn, Hesheng Liu

    Publicerad 2020
    Hämta fulltext Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  14. 14
    TSPO imaging using the novel PET ligand [18F]GE-180: quantification approaches in patients with multiple sclerosis

    TSPO imaging using the novel PET ligand [18F]GE-180: quantification approaches in patients with multiple sclerosis av Lena Vomacka, Nathalie L. Albert, Simon Lindner, Marcus Unterrainer, Christoph Mahler, Matthias Brendel, Larissa Ermoschkin, Astrid Gosewisch, Anika Brunegraf, Christopher Buckley, Tania Kümpfel, Rainer Rupprecht, Sibylle Ziegler, Martin Kerschensteiner, Peter Bartenstein, Guido Böning

    Publicerad 2017
    Hämta fulltext Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  15. 15
    PET/CT imaging for evaluation of multimodal treatment efficacy and toxicity in advanced NSCLC—current state and future directions

    PET/CT imaging for evaluation of multimodal treatment efficacy and toxicity in advanced NSCLC—current state and future directions av Chukwuka Eze, Nina-Sophie Schmidt-Hegemann, Lino M. Sawicki, Julian Kirchner, Olarn Roengvoraphoj, Lukas Käsmann, Lena M. Mittlmeier, Wolfgang G. Kunz, Amanda Tufman, Julien Dinkel, Jens Ricke, Claus Belka, Farkhad Manapov, Marcus Unterrainer

    Publicerad 2021
    Hämta fulltext Hämta fulltext
    Revisão
    Lägg till i favoriter
    Sparad:
  16. 16
    PSMA Expression in Glioblastoma as a Basis for Theranostic Approaches: A Retrospective, Correlational Panel Study Including Immunohistochemistry, Clinical Parameters and PET Imaging

    PSMA Expression in Glioblastoma as a Basis for Theranostic Approaches: A Retrospective, Correlational Panel Study Including Immunohistochemistry, Clinical Parameters and PET Imagin... av Adrien Holzgreve, Annamaria Biczok, Viktoria Ruf, Friederike Liesche‐Starnecker, Katja Steiger, Maximilian A. Kirchner, Marcus Unterrainer, Lena M. Mittlmeier, Jochen Herms, Jürgen Schlegel, Peter Bartenstein, Jörg‐Christian Tonn, Nathalie L. Albert, Bogdana Suchorska

    Publicerad 2021
    Hämta fulltext Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  17. 17
    Cost-Effectiveness Analysis of 177Lu-PSMA-617 Radioligand Therapy in Metastatic Castration-Resistant Prostate Cancer

    Cost-Effectiveness Analysis of 177Lu-PSMA-617 Radioligand Therapy in Metastatic Castration-Resistant Prostate Cancer av Dirk Mehrens, Kristina K. M. Kramer, Lena M. Unterrainer, Leonie Beyer, Peter Bartenstein, Matthias F. Froelich, Fabian Tollens, Jens Ricke, Johannes Rübenthaler, Nina-Sophie Schmidt-Hegemann, Annika Herlemann, Marcus Unterrainer, Wolfgang G. Kunz

    Publicerad 2023
    Hämta fulltext Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  18. 18
    Comparison of the Hematotoxicity of PRRT with Lutathera® and Locally Manufactured 177Lu-HA-DOTATATE in Patients with Neuroendocrine Tumors and the Impact of Different Application Intervals

    Comparison of the Hematotoxicity of PRRT with Lutathera® and Locally Manufactured 177Lu-HA-DOTATATE in Patients with Neuroendocrine Tumors and the Impact of Different Application I... av Markus Hofmann, Sophie C. Kunte, Marcus Unterrainer, Astrid Delker, Adrien Holzgreve, Johannes Toms, F.J. Gildehaus, Christoph J. Auernhammer, Christine Spitzweg, Mathias J. Zacherl, Harun Ilhan, Johannes Rübenthaler, Leonie Beyer, Lena M. Unterrainer

    Publicerad 2025
    Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  19. 19
    Photopenic defects on O-(2-[18F]-fluoroethyl)-L-tyrosine PET: clinical relevance in glioma patients

    Photopenic defects on O-(2-[18F]-fluoroethyl)-L-tyrosine PET: clinical relevance in glioma patients av Norbert Galldiks, Marcus Unterrainer, Natalie Judov, Gabriele Stoffels, Marion Rapp, Philipp Lohmann, Franziska Vettermann, Veronika Dunkl, Bogdana Suchorska, Jörg C. Tonn, Friedrich-Wilhem Kreth, Gereon R. Fink, Peter Bartenstein, Karl‐Josef Langen, Nathalie L. Albert

    Publicerad 2019
    Hämta fulltext Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  20. 20
    Recent advances of PET imaging in clinical radiation oncology

    Recent advances of PET imaging in clinical radiation oncology av Marcus Unterrainer, Chukwuka Eze, Harun Ilhan, Sebastian Marschner, Olarn Roengvoraphoj, Nina-Sophie Schmidt-Hegemann, Franziska Walter, W. G. Kunz, Per Munck af Rosenschöld, Robert Jeraj, Nathalie L. Albert, Anca‐Ligia Grosu, Maximilian Niyazi, Peter Bartenstein, Claus Belka

    Publicerad 2020
    Hämta fulltext Hämta fulltext
    Revisão
    Lägg till i favoriter
    Sparad:

Sökverktyg: